Literature DB >> 9619448

Recombinant soluble low density lipoprotein receptor fragment inhibits minor group rhinovirus infection in vitro.

T C Marlovits1, T Zechmeister, M Gruenberger, B Ronacher, H Schwihla, D Blaas.   

Abstract

A fragment of the low density lipoprotein receptor encompassing the seven ligand binding repeats was expressed in Sf9 insect cells as a fusion protein with a carboxyl-terminally linked hexa-his tag by using a baculovirus vector. Up to 10 mg/l of the fusion protein was secreted into the medium. The material was soluble in the absence of detergent and active in binding beta very low density lipoprotein and a member of the minor group of human rhinoviruses (HRV2) in ligand blots from sodium dodecyl sulfate-polyacrylamide gels run under nonreducing conditions. The receptor fragment specifically inhibits viral infection of HeLa cells by minor group HRVs in a concentration-dependent manner. Viral infectivity is neutralized by aggregation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9619448     DOI: 10.1096/fasebj.12.9.695

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  17 in total

1.  Viral evolution toward change in receptor usage: adaptation of a major group human rhinovirus to grow in ICAM-1-negative cells.

Authors:  A Reischl; M Reithmayer; G Winsauer; R Moser; I Gösler; D Blaas
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

2.  The cellular receptor to human rhinovirus 2 binds around the 5-fold axis and not in the canyon: a structural view.

Authors:  E A Hewat; E Neumann; J F Conway; R Moser; B Ronacher; T C Marlovits; D Blaas
Journal:  EMBO J       Date:  2000-12-01       Impact factor: 11.598

3.  Inhibition of polyprotein processing and RNA replication of human rhinovirus by pyrrolidine dithiocarbamate involves metal ions.

Authors:  B M Krenn; B Holzer; E Gaudernak; A Triendl; F J van Kuppeveld; J Seipelt
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

4.  Infection and propagation of human rhinovirus C in human airway epithelial cells.

Authors:  Weidong Hao; Katie Bernard; Nita Patel; Nancy Ulbrandt; Hui Feng; Catherine Svabek; Susan Wilson; Christina Stracener; Kathy Wang; Joann Suzich; Wade Blair; Qing Zhu
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

5.  Interactions of foot-and-mouth disease virus with soluble bovine alphaVbeta3 and alphaVbeta6 integrins.

Authors:  Hernando Duque; Michael LaRocco; William T Golde; Barry Baxt
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

6.  Identification of the human rhinovirus serotype 1A binding site on the murine low-density lipoprotein receptor by using human-mouse receptor chimeras.

Authors:  Barbara Herdy; Luc Snyers; Manuela Reithmayer; Peter Hinterdorfer; Dieter Blaas
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

7.  Species-specific receptor recognition by a minor-group human rhinovirus (HRV): HRV serotype 1A distinguishes between the murine and the human low-density lipoprotein receptor.

Authors:  Manuela Reithmayer; Andrea Reischl; Luc Snyers; Dieter Blaas
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

Review 8.  Evolution of cell recognition by viruses: a source of biological novelty with medical implications.

Authors:  Eric Baranowski; Carmen M Ruiz-Jarabo; Nonia Pariente; Nuria Verdaguer; Esteban Domingo
Journal:  Adv Virus Res       Date:  2003       Impact factor: 9.937

9.  Very-low-density lipoprotein receptor fragment shed from HeLa cells inhibits human rhinovirus infection.

Authors:  T C Marlovits; C Abrahamsberg; D Blaas
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

10.  Effect of bafilomycin A1 and nocodazole on endocytic transport in HeLa cells: implications for viral uncoating and infection.

Authors:  N Bayer; D Schober; E Prchla; R F Murphy; D Blaas; R Fuchs
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.